A new highly transmissible COVID-19 variant called Stratus is on the rise in the U.S., accounting for about 85% of cases, with symptoms similar to earlier strains. Prevention and treatment remain consistent with previous COVID protocols, and existing vaccines are still considered effective. Recent changes in vaccination guidelines now recommend individual decision-making rather than universal vaccination, leading to some confusion.
A new COVID-19 variant called XFG or 'Stratus' has become the dominant strain in the U.S., characterized by a severe sore throat described as a 'razor blade' sensation, along with other symptoms like cough, congestion, and fatigue. It has rapidly overtaken previous strains, with high case levels in several states, despite limited vaccine access in some areas.
A new Covid strain called 'Stratus', with variants XFG and XFG.3, is spreading in England, causing symptoms similar to previous strains, notably a hoarse voice, but without increased severity. Vaccines remain effective, and government guidance on testing and restrictions remains unchanged.
Covid cases are rising in the UK due to new variants Nimbus and Stratus, which do not seem more dangerous but may cause distinctive symptoms like a sore throat. Experts recommend vaccination, especially for vulnerable groups, and continued precautions to prevent spread as reinfections remain possible. Testing is less accessible for free, but available at pharmacies and clinics.
Health experts in Ireland warn that the new Covid variant, Stratus, is spreading rapidly with subtle symptoms like hoarseness that are often overlooked, despite a decline in overall cases. The variant now accounts for over 76% of new infections and is characterized by increased transmissibility and a wider range of symptoms, though it doesn't seem to cause more severe illness. Public health guidance remains unchanged, emphasizing awareness of all Covid symptoms.
A new COVID variant called Stratus (XFG) is spreading in the US, with symptoms similar to other variants including hoarseness, fever, cough, and loss of taste or smell. The variant, first identified in Southeast Asia, now accounts for about 14% of cases and is considered low risk by WHO. COVID cases are rising across 40 states, especially in the South, Mid-Atlantic, Northeast, and Midwest, following typical seasonal waves.
A new COVID variant called XFG or 'Stratus' is spreading in the U.S. and globally, accounting for up to 14% of cases in the U.S. as of late June. It is a combination of variants F.7 and LP.8.1.2, with mutations that may help it evade immune responses but is less contagious and not associated with more severe disease. Current vaccines are expected to remain effective against it, and symptoms are similar to other COVID variants, with some reports of hoarseness.
A new Covid variant called Stratus (XFG) has become dominant in the UK, characterized by a unique symptom of hoarseness. Despite mutations that may help it evade immunity, it appears to cause no more severe illness than previous Omicron variants, and the WHO considers the global risk low.
